Improvement of an ultrasensitive human immunodeficiency virus Type 1 real-time reverse transcriptase-polymerase chain reaction targeting the long terminal repeat region

Transfusion

Volumn 50, Issue 3, 2010, Pages 685-692

  Edelmann, Anke ^a   Kalus, Ulrich ^b   Oltmann, Anke ^b   Stein, Angela ^b   Unbehaun, Anett ^b   Drosten, Christian ^b   Krüger, Detlev H ^b   Hofmann, Jörg ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; PRIMER DNA; VIRUS RNA;

ARTICLE; BLOOD DONOR; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; NONHUMAN; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; VIRUS STRAIN;

ADULT; ANTIBODIES, VIRAL; BLOOD DONORS; DONOR SELECTION; GENETIC VARIATION; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY;

EID: 77649206986     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02477.x     Document Type: Article

References (32)

1. van de Laar M, Likatavicius G, Stengaard A, Donoghoe M. HIV/AIDS surveillance in Europe: update 2007. Euro Surveill 2008 13 : 19066.
2. Cohen M, Hellmann N, Levy J, DeCock K, Lange J. The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J Clin Invest 2008 118 : 1244 54.
3. Stramer S, Glynn S, Kleinman S, Strong DM, Caglioti S, Wright DJ, Dodd RY, Busch MP National Heart, Lung, and Blood Institute Nucleic Acid Test Study Group. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004 351 : 760 8.
4. Kalus U, Edelmann A, Pruss A, Hofmann J, Kiesewetter H, Krüger DH, Salama A. Noninfectious transfusion of platelets donated before detection of human immunodeficiency virus RNA in plasma. Transfusion 2009 49 : 435 9.
5. Busch M, Kleinman S, Jackson B, Stramer SL, Hewlett I, Preston S. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases. Transfusion 2000 40 : 143 59.
6. Bagchi S, Kempf M, Westfall A, Maherya A, Willig J, Saag MS. Can routine clinical markers be used longitudinally to monitor antiretroviral therapy success in resource-limited settings? Clin Infect Dis 2007 44 : 135 8.
7. Hammer S, Eron JJ, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, Jacobrsen DM, Montaner JS, Richman DD, Yeni PG, Volberding PA International AIDS Society-USA. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA Panel. JAMA 2008 300 : 555 70.
8. Wensing A, van de Vijver D, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Costagliola D, De Luca A, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelman A, Horban A, Korn K, Kücherer C, Leitner T, Loveday C, MacRae E, Maljkovic I, de Mendoza C, Meyer L, Nielsen C, Op de Coul EL, Ormaasen V, Paraskevis D, Perrin L, Puchhammer-Stöckl E, Ruiz L, Salminen M, Schmit JC, Schneider F, Schuurman R, Soriano V, Stanczak G, Stanojevic M, Vandamme AM, Van Laethem K, Violin M, Wilbe K, Yerly S, Zazzi M, Boucher CA SPREAD Programme. Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management. J Infect Dis 2005 192 : 958 66.
9. Swanson P, de Mendoza C, Joshi Y, Golden A, Hodinka RL, Soriano V, Devare SG, Hackrett J Jr. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT. J Clin Microbiol 2005 43 : 3860 8.
10. Gueudin M, Plantier J, Lemée V, Schmitt MP, Chartier L, Bourlet T, Ruffault A, Damond F, Vray M, Simon F. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J Acquir Immune Defic Syndr 2007 44 : 500 5.
11. Schumacher W, Frick E, Kauselmann M, Maier-Hoyle V, van der Vliet R, Babiel R. Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system. J Clin Virol 2007 38 : 304 12.
12. Drosten C, Panning M, Drexler JF, Hänsel F, Pedroso C, Yeats J, de Souza Luna LK, Samuel M, Liedigk B, Lippert U, Stürmer M, Doerr HW, Brites C, Preiser W. Ultrasensitive monitoring of HIV-1 viral load by a low-cost real-time reverse transcription-PCR assay with internal control for the 5′ long terminal repeat domain. Clin Chem 2006 52 : 1258 66.
13. Müller J, Eis-Hübinger A, Däumer M, Kaiser R, Rox JM, Gurtler L, Hanfland P, Potzsch B. A novel internally controlled real-time reverse transcription-PCR assay for HIV-1 RNA targeting the pol integrase genomic region. J Virol Methods 2007 142 : 127 35.
14. Rouet F, Ménan H, Viljoen J, Ngo-Giang-Huong N, Mandaliya K, Valéa D, Lien TX, Danaviah S, Rousset D, Ganon A, Nerrienet E. In-house HIV-1 RNA real-time RT-PCR assays: principle, available tests and usefulness in developing countries. Expert Rev Mol Diagn 2008 8 : 635 50.
15. Abe M, Klett C, Wieland E, Gille S, Landt O. Two-step real-time PCR quantification of all subtypes of human immunodeficiency virus type 1 by an in-house method using locked nucleic acid-based probes. Folia Med (Plovdiv) 2008 50 : 5 13.
16. Korber BT, Foley BF, Kuiken CL, Pillai SK, Sodroski JG. Numbering positions in HIV relative to HXB2CG. Los Alamos (NM) : Los Alamos National Laboratory 1998, III-102, III-11.
17. Christopherson C, Sninsky J, Kwok S. The effects of internal primer-template mismatches on RT-PCR: HIV-1 model studies. Nucleic Acids Res 1997 25 : 654 8.
18. Kwok S, Kellogg DE, McKinney N, Spasic D, Goda L, Levenson C, Sninsky JJ. Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies. Nucleic Acids Res 1990 18 : 999 1005.
19. Pereyra F, Palmer S, Miura T, Block BL, Wiegand A, Rothchild AC, Baker B, Rosenberg R, Cutrell E, Seaman MS, Coffin JM, Walker BD. Persistent low level viremia in HIV-1 elite controllers and relationship to immunologic parameters. J Infect Dis 2009 200 : 984 90.
20. Ferre AL, Hunt PW, Critchfield JW, Young DH, Morris MM, Garcia JC, Pollard RB, Yee HF Jr., Martin JN, Deeks SG, Shacklett BL. Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. Blood 2009 113 : 3978 89.
21. Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, Geusendam G, Gubbe K, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ German Red Cross NAT Study Group. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Transfusion 2008 48 : 1558 66.
22. Schmidt M, Korn K, Nübling M, Chudy M, Geusendam G, Hennig H, Sireis W, Rabenau HF, Doerr HW, Berger A, Hourfar MK, Gubbe K, Karl A, Gürtler L, Seifried E. First transmission of HIV-1 by a cellular blood product after mandatory NAT blood screening in Germany. Vox Sang 2008 95 : 56.
23. Babic D, Poljak M, Seme K, Tomazic J, Vidmar L. Molecular epidemiology of HIV-1 subtypes based on analysis of pol sequences in Slovenia, 1996-2005. J Med Virol 2006 78 : 997 1002.
24. Thomson M, Najera R. Increasing HIV-1 genetic diversity in Europe. J Infect Dis 2007 196 : 1120 4.
25. Anderson J. Coming and going: some aspects of care for migrants with HIV in the UK. J Infect 2008 57 : 11 5.
26. Yebra G, Rivas P, Herrero M, López M, de Mulder M, Puente S, Ramírez-Olivencia G, Soriano V, Holguín A. Clinical differences and viral diversity between newly HIV type 1-diagnosed African and non-African patients in Spain (2005-2007). AIDS Res Hum Retroviruses 2009 25 : 37 44.
27. Drosten C, Seifried E, Roth WK. TaqMan 5′-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening. J Clin Microbiol 2001 39 : 4302 8.
28. Gottesman BS, Grosman Z, Lorber M, Levi I, Shitrit P, Mileguir F, Gottesman G, Chowers MY. Measurement of HIV RNA in patients infected by subtype C by assays optimized for subtype B results in an underestimation of the viral load. J Med Virol 2004 73 : 167 71.
29. Treadwell TL, Fleisher J. Underestimation of HIV-1 plasma viral burden in patients who acquire infection abroad: the experience in a community hospital clinic. Arch Intern Med 2003 163 : 1613 4.
30. Gueudin M, Simon F. Plasma RNA viral load in HIV-1 group O infection by real-time PCR. Methods Mol Biol 2005 304 : 221 8.
31. Drexler JF, de Souza Luna LK, Pedroso C, Pedral-Sampaio DB, Queiroz AT, Brites C, Netto EM, Drosten C. Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil. J Clin Microbiol 2007 45 : 2061 3.
32. Schvachsa N, Turk G, Burgard M, Dilernia D, Carobene M, Pippo M, Gomez-Carrillo M, Rouzioux C, Salomon H. Examination of real-time PCR for HIV-1 RNA and DNA quantitation in patients infected with HIV-1 BF intersubtype recombinant variants. J Virol Methods 2007 140 : 222 7.